Clinical trial
Mylan Insulin Aspart Study
NCT03760068
Study timeline
Study start (actual)2018-11-07Date precision: day
Registry last updated2022-02-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 1unresolved
Interventions
Sponsors & collaborators
Mylan Inc.lead sponsor
Mylan GmbHcollaborator
Mapped research locations
MiamiFlorida, United States10HoustonTexas, United States6DallasTexas, United States5San AntonioTexas, United States3New YorkNew York, United States2NashvilleTennessee, United States2PhoenixArizona, United States2OrlandoFlorida, United States2OmahaNebraska, United States2LexingtonKentucky, United States2ChattanoogaTennessee, United States2BostonMassachusetts, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03760068 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.